Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2025
Universal screening for congenital Cytomegalovirus infection using saliva from the neonate.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Halwachs-Baumann Gabriele, Wagner Oliver, Salaheddin Yarub, Ziebermayr Eveline, Angleitner-Boubenizek Lukas, Grüßenberger Georg, Folger-Buchegger Ulla
Аннотация
BACKGROUND: Congenital Cytomegalovirus infection (cCMV) is the most common intrauterine infection in developed countries. The diagnostic gold standard is detection of CMV in neonatal urine. Considering difficulties in urine sample collection, saliva is an alternative specimen providing supportive material for early diagnosis and timely intervention.
OBJECTIVES: Aim of this study was to evaluate a universal screening program using saliva as target specimen, and urine as confirmatory material.
RESULTS: Between May 2019 and November 2024, 5168 newborns were screened for CMV shedding in saliva, 45 neonates were tested positive. From 44 neonates a urine sample was examined. Twelve out of forty-four neonates had concordant results (prevalence = 0,232 %) with five newborns showing CMV related symptoms. In saliva, the difference between the Ct-value of the cCMV negative and the cCMV positive group was significant (38.59 vs. 28.56, p-value < 0.0001). At a Ct-value cut-off of 38.8 sensitivity was 100 %, specificity 53.1 %, positive predictive value 44 %, and negative predictive value 100 %. ROC analysis yielded an AUC value of 0.930. The mean virus load in urine was 31,266,663 copies/ml.
DISCUSSION: This study reports a prevalence of 0,232 % for cCMV infection in the catchment area of the hospital Steyr. PCR based CMV detection in saliva is a good screening tool, but one must be aware of false positive results, arising from possible contamination. In our cohort CMV positive vaginal or cervical secretion seems more likely being the source of contamination than CMV positive breast milk. The high false positive rate in saliva makes confirmatory testing in urine samples mandatory.
OBJECTIVES: Aim of this study was to evaluate a universal screening program using saliva as target specimen, and urine as confirmatory material.
RESULTS: Between May 2019 and November 2024, 5168 newborns were screened for CMV shedding in saliva, 45 neonates were tested positive. From 44 neonates a urine sample was examined. Twelve out of forty-four neonates had concordant results (prevalence = 0,232 %) with five newborns showing CMV related symptoms. In saliva, the difference between the Ct-value of the cCMV negative and the cCMV positive group was significant (38.59 vs. 28.56, p-value < 0.0001). At a Ct-value cut-off of 38.8 sensitivity was 100 %, specificity 53.1 %, positive predictive value 44 %, and negative predictive value 100 %. ROC analysis yielded an AUC value of 0.930. The mean virus load in urine was 31,266,663 copies/ml.
DISCUSSION: This study reports a prevalence of 0,232 % for cCMV infection in the catchment area of the hospital Steyr. PCR based CMV detection in saliva is a good screening tool, but one must be aware of false positive results, arising from possible contamination. In our cohort CMV positive vaginal or cervical secretion seems more likely being the source of contamination than CMV positive breast milk. The high false positive rate in saliva makes confirmatory testing in urine samples mandatory.